Newsmeme!
Discover News you didn't know existed
Darmstadt, December 1, 2008 – Merck Serono, a division of Merck KGaA, announced today that it has received approval from the European Commission to extend the use of its targeted therapy Erbitux® (cetuximab) to include 1st-line treatment of patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck (SCCHN). Erbitux was previously approved for use in combination ...
No tags found at this time. Be the first to tag this news item, learn more.
A HEALTHY FUTURE IN PHARMACEUTICAL SALES? - PharmiWeb
The pharmaceutical industry has often been described as counter-recessionary, the broad logic being that people will always get sick, and hence there will be a continuous demand for drugs. And whilst this may be true at a surface level, a more ...
NPA Member Event To Be Held At UCA Conference - PharmiWeb
The NPA will be holding a member event at the UCA Conference 2008 on Saturday 8 November at the Galgorm Resort & Spa in Ballymena. The topic of the NPA event is â??The future of my business is scripts vs The future of my business is servicesâ ...
None found at this time.
Related News Resources:
> HGH News
|
Breaking News
and Top Stories |
Business
Earnings, Economy, Personal Finance, and Stock Markets |
Entertainment
Books, Celebrity, Fashion, Movies, Music, Television, and Theatre |
Health
Aging, Diseases, Medical Conditions, Medications, Sexual Health, and Weight Loss |
Politics
Congress, Supreme Court, and White House |
|
Science
Animals, Astronomy, Biotechnology, Space, and Weather |
Sports
Baseball, Basketball, Boxing, Football, Golf, Hockey, Motor Sports, Soccer, and Tennis |
Technology
Communications, Hardware, Internet, Personal Technology, and Software |
United States
and Crimes and Trials |
World
Africa, Antartica, Asia, Australia, Canada, Europe, Latin America, and Middle East |